ApconiX is delighted to welcome Ian Slater to the team.  Ian has spent many years in the pharmaceutical industry as a toxicology Study Director and Study Monitor and he joins our nonclinical study monitoring team.  Ian was previously an Associate Principal Toxicologist in the Regulatory Safety group at AstraZeneca and has a wealth of experience in multiple study types and working with Contract Research Organisations (CRO).

Ian has both a bachelor’s and master’s degree in Applied Biology.  He has worked in a variety of roles at ICI, Zeneca and AstraZeneca.  A member of the British Toxicology Society, Ian was Chair of the Study Director Workshop at BTS from 2011-2015, providing a forum of the sharing of good practice and the development of junior toxicologists.

Ian commented, “It is brilliant to be back working alongside Guy and Richard again.  I enjoy being part of a team and I am looking forward to bringing my skills and experience to ApconiX and their clients.”

“Ian is a terrific addition to our Study Monitoring team” added Dr Richard Knight, Director and Co-Founder of ApconiX. “The Study Monitor, working with CRO study personnel and the Sponsor, is an incredibly valuable combination and bringing in someone of Ian’s knowledge and experience gives us a lot of additional capability in this area.”